Burrill & Co. and the Infinity Group are joining forces to pursue investments in Chinese life science companies.
San Francisco-based Burrill, a venture capital/private equity player, and Israel- and Chine-based Infinity will co-invest in U.S. dollars and Chinese renminbi as equal partners, according to a press release.